跳至主要内容
临床试验/KCT0000203
KCT0000203招募中未知

Prevention of Post-ERCP Pancreatitis by Combination of Udenafil and Aceclofenac in High-risk Patients: Prospective, Randomized, Placebo-controlled, Double blind, Multicenter Study

Chung-Ang Univerisity Hospital0 个研究点目标入组 226 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
226

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1) Patients who required ERCP for diagnosis or treatment
  • 2) Patients who have an acceptable cardiopulmonary status for ERCP
  • 3) Patients who have no risk for aggravation of cardiac function by taking udenafil
  • 4) Patient who are 20-80 year-old and meet one of following
  • (1) Suspected sphincter of Oddi dysfunction
  • (2) Diameter of extrahepatic bile duct < or = 8mm
  • (3) pancreatography is required during ERCP

排除标准

  • 1) Need for emergency ERCP
  • 2) Chronic pancreatitis
  • 3) Acute pancreatitis within 72 hours before ERCP
  • 4) Sphincterotomy or sphincterplasty state
  • 5) Periampullary cancer involving sphincter of Oddi
  • 6) Stroke, MI, CABG within 6m
  • 7) Cardiac failure, unstable angina within 6m
  • 8) NSAIDs within 1 week

研究者

发起方
Chung-Ang Univerisity Hospital

相似试验